Boron Cluster Chemistry and Neutron Capture Therapy
This research community develops boron-containing compounds and neutron beam systems to treat cancer with boron neutron capture therapy (BNCT), a method that delivers radiation directly to tumor cells.
The work centers on the synthesis of boron clusters, such as carboranes, and their integration into drug delivery agents for targeted cancer treatment. It also encompasses the design of compact neutron sources, accelerator-based systems, and Monte Carlo simulations used to model neutron flux and dose distribution. Key applications include treating head and neck cancers and brain tumors, with a strong focus on optimizing the delivery of boron to tumor sites while minimizing damage to surrounding healthy tissue.
The community is most heavily concentrated in boron research, accounting for 5.8% of all tracked boron papers, with 5,834 papers in this group. Beryllium research also features prominently, where this community represents 1.4% of the total output.
There are 18,742 papers in this community, primarily published in Applied Radiation and Isotopes, Inorganic Chemistry, and Radiation Protection Dosimetry.
Recent work includes the development of boron cluster agents for BNCT, the use of boron nanoparticles for targeted radiotherapy and immunotherapy, and the application of photocatalysis for B–H activation in carborane clusters.